What About Amgen : Part Two

Even if Amgen is seeing some weakness because of European austerity or less people visiting the doctor in the US, I believe the stock is a buy on weakness. At this price everything is priced in and then some. I just don't want to buy today because I don't want to step in front of that possible weakness. Amgen reports tonight.

No comments: